Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conmed Corp Issues FY 2013 Guidance In Line With Analysts' Estimates-Conference Call


Thursday, 17 Jan 2013 06:30pm EST 

Conmed Corp announced that for fiscal 2013, it expects revenue to grow close to $800 million and earnings per share (EPS) in the range of $1.80-$1.90. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $796 million and EPS of $1.85 for fiscal 2013. 

Company Quote

42.72
-0.04 -0.09%
22 Jul 2014